跳至主要内容
临床试验/ISRCTN21955180
ISRCTN21955180已完成未知

A double-blind randomised controlled trial comparing standard dose of iron supplementation for pregnant women with two screen-and-treat approaches using hepcidin as a biomarker for ready and safe to receive iron

The Medical Research Council (MRC) (UK)0 个研究点目标入组 498 人开始时间: 2014年4月14日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
498

研究概览

简要总结

  1. 2016 protocol in: https://www.ncbi.nlm.nih.gov/pubmed/27411564 2. 2019 results in https://www.ncbi.nlm.nih.gov/pubmed/31607468 (added 15/10/2019)

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 1. Pregnant (gestational age between 14 - 22 weeks)
  • 2. Age: 18 to 45 years
  • 3. Likely to be resident in study area for duration of trial
  • 4. Written informed consent obtained

排除标准

  • 1. Severely anaemic (< 7 g/dl)
  • 2. Seriously ill (infectious disease of clinical significance) at recruitment
  • 3. Chronic disease
  • 4. Pregnancy complications (e.g. pre-eclampsia) at enrolment
  • 5. Already part of another study

研究者

发起方
The Medical Research Council (MRC) (UK)

相似试验